ANKRD36BP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.362200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.498400E-01
Normal-vs-Stage2
2.202600E-01
Normal-vs-Stage3
1.321390E-01
Normal-vs-Stage4
7.487800E-01
Stage1-vs-Stage2
6.124800E-01
Stage1-vs-Stage3
1.096580E-01
Stage1-vs-Stage4
3.428000E-01
Stage2-vs-Stage3
1.487240E-01
Stage2-vs-Stage4
3.582600E-01
Stage3-vs-Stage4
1.917630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.308000E-01
Normal-vs-AfricanAmerican
9.088000E-01
Normal-vs-Asian
7.923900E-02
Caucasian-vs-AfricanAmerican
1.526380E-01
Caucasian-vs-Asian
1.770630E-01
AfricanAmerican-vs-Asian
3.950200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.173600E-01
Normal-vs-Female
2.848800E-01
Male-vs-Female
9.446800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.070600E-01
Normal-vs-Age(41-60Yrs)
5.220000E-01
Normal-vs-Age(61-80Yrs)
1.720970E-01
Normal-vs-Age(81-100Yrs)
6.006400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.129000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.638400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.251600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.455700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.605600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.734180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.181750E-01
Normal-vs-Daily Drinker
3.394200E-02
Normal-vs-Weekly Drinker
2.197200E-01
Normal-vs-Occasional Drinker
3.385000E-01
Normal-vs-Social Drinker
6.136600E-01
Non Drinker-vs-Daily Drinker
1.179010E-01
Non Drinker-vs-Weekly Drinker
9.930600E-01
Non Drinker-vs-Occasional Drinker
3.170000E-01
Non Drinker-vs-Social Drinker
1.305180E-01
Daily Drinker-vs-Weekly Drinker
2.220200E-01
Daily Drinker-vs-Occasional Drinker
2.577900E-02
Daily Drinker-vs-Social Drinker
1.437670E-02
Weekly Drinker-vs-Occasional Drinker
4.447400E-01
Weekly Drinker-vs-Social Drinker
2.555400E-01
Occasional Drinker-vs-Social Drinker
5.686400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
N/A
Normal-vs-Grade 2
N/A
Normal-vs-Grade 3
N/A
Normal-vs-Grade 4
N/A
Grade 1-vs-Grade 2
2.919600E-01
Grade 1-vs-Grade 3
1.286150E-01
Grade 1-vs-Grade 4
N/A
Grade 2-vs-Grade 3
3.107400E-01
Grade 2-vs-Grade 4
N/A
Grade 3-vs-Grade 4
N/A
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.833950E-01
Normal-vs-NonDiabetic
1.018210E-01
Diabetic-vs-NonDiabetic
7.291600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.739400E-01
Normal-vs-NoPancreatitis
1.530010E-01
Pancreatitis-vs-NoPancreatitis
3.940800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.711000E-01
Normal-vs-N1
2.116000E-01
N0-vs-N1
7.181600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.892200E-01
Normal-vs-TP53-NonMutant
4.490800E-01
TP53-Mutant-vs-TP53-NonMutant
8.965000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
